Adiponectin is a protein hormone produced by adipose tissue whose circulating levels are inversely related to adiposity and inflammation. Adiponectin circulates as oligomers, from the low molecular weight trimer to the high molecular weight octodecamer (18mer) Each oligomer has distinct biological activities, which include enhancement of insulin sensitivity and metabolic control, and suppression of inflammation. Adiponectin occurs in human milk at higher concentrations than leptin. The adiponectin in human milk is almost entirely of the high molecular weight form, the form with the highest activity in controlling many types of metabolic processes. Human adiponectin fed to infant mice is transported across the intestinal mucosa into the serum. An inverse relationship between adiponectin levels in milk and adiposity (weight-for-height) of the breastfed infant was observed, and could be due to modulation of infant metabolism by milk adiponectin, and may be related to the observed protection against obesity by breastfeeding. Human milk may be a medium whereby the hormonal milieu (in response to internal factors and the environment) of the mother can be used to communicate with the breastfed infant to modify infant metabolic processes. Transmission of information from mother to infant through milk may allow adaptation to fluctuating environmental conditions.
Keywords infant development; body weight; BMI; adiposity
AdiponectinObesity in children has reached epidemic proportions, with obesity-related disorders that had typically been diseases of adults now occurring in children. Several reports describe an association between feeding human milk and reduced obesity later in life. Likewise, inflammatory bowel diseases are an increasingly important problem in pediatrics, and there is evidence of protection by human milk. The mechanisms by which human milk could provide , and all potential conflicts of interest have been disclosed to the NIH and are being managed by Massachusetts General Hospital and Cincinnati Children's Hospital, respectively. Jessica Woo, Ph.D. has no affiliation with entitles having financial interests in the subject discussed in this article. Mead Johnson Nutrition sponsored a symposium and provided an honorarium to participants. This review of the symposium presentation was written exclusively by the authors, who have no financial interests in production or sales of infant formula.Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Adiponectin, a protein produced in adipose tissue, is a potent metabolic mediator that controls processes associated with obes...